LA JOLLA, Calif. , September 30, 2005
The Burnham Institute for Medical Research today announced the election of seven new members to its Board of Trustees and named Nicolas "Nico" Nierenberg as Chairman of the Board. The Burnham's Board of Trustees is comprised of philanthropists, industry thought leaders, entrepreneurs, and renowned researchers.
New members elected to the Board include:
- David Hale, President and CEO of CancerVax Corporation, Carlsbad, CA
- Brent Jacobs, Senior VP of Burnham Real Estate Services' Life Science Group, San Diego, CA
- Greg Lucier, Chairman and CEO of Invitrogen Corporation, Carlsbad, CA
- Stuart Tanz, President and CEO of Pan Pacific Retail Properties, San Diego, CA
- Scott South, President and CEO of Stevens Water Monitoring System, Inc., Portland, OR
- Barbara Warren, Board member, Lymphoma Research Foundation, residing in Rancho Santa Fe, CA, and Greenwich, CT
- Diane Winokur, Principal of Winokur Associates, Trustee, ALS Association, residing in San Francisco and Napa, CA
"This Institute is a springboard for scientific innovation, borne of a highly collaborative mix of scientists and research disciplines. I look forward to working with our Board in partnership with our scientists as they make the discoveries that lead to new ways to diagnose and treat diseases," said Nico Nierenberg. "I am honored to be a part of this prestigious organization."
Nico Nierenberg, a La Jolla native, assumes leadership as Chairman with over 20 years of experience in the software industry. He founded Actuate Corporation in 1993 and co-founded Unify Corporation, which develops and markets relational database development tools. He was the chief technical visionary at Unify and has been responsible for the development and design of a number of new software products and applications. He studied economics and computer sciences at UCLA and UCSD.
New members of the Board include leaders of San Diego's biotechnology industry. Greg Lucier is the Chairman and CEO of Carlsbad-based Invitrogen Corporation, which provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. David Hale is the president and CEO of CancerVax Corporation, a biotechnology company focused on research, development and commercialization of novel biological products for the treatment and control of cancer.
Brent Jacobs is a founder of Biocom, a premiere life science industry association representing more than 450 member companies in San Diego and Southern California, and chairs the Life Science Division of ONCOR International. Jacobs is a senior vice president with Burnham Real Estate Service's Life Science Group and has authored several articles on biomedical real estate.
Prominent business leaders elected to the board include Stuart Tanz and Scott South. With over 20 years of experience in real estate, Stuart Tanz has been the chairman, CEO, and president of Pan Pacific Retail Properties since its inception as a public company in 1997. Scott South, the CEO of Stevens Water Monitoring System, Inc., is the chairman of the Board of the National College of Naturopathic Medicine in Portland, Oregon and has contributed to several philanthropic causes.
Several of the new trustees bring their non-profit experience to the Institute. Barbara Warren serves on the national board of the Lymphoma Research Foundation, whose mission is to eradicate lymphoma and serve those touched by the disease. Diane Winokur is the principal of Winokur Associates, a management consulting firm in San Francisco, and Chair of the board of the UCSF ALS (Lou Gehrig's Disease) Center. She is a trustee in the national and Bay-area ALS Association patient-advocacy groups.
"We are honored to welcome these outstanding individuals to the Board," said John Reed, Ph.D., M.D., President and CEO of The Burnham Institute for Medical Research. "We look forward to combining their expertise and guidance to continue in our mission to perform outstanding basic research in the life-sciences and to provide the foundation of knowledge that is critical to medical progress."